CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C20004 | BRD-K55295918 | BRD-K55295918 | -- | -- | -- | Details |
| C20005 | BRD-K55297678 | BRD-K55297678 | -- | -- | -- | Details |
| C20006 | BRD-K55300135 | BRD-K55300135 | -- | -- | -- | Details |
| C20007 | BRD-K55301415 | abiraterone | CYP17A1 | Androgen biosynthesis inhibitor | -- | Details |
| C20008 | BRD-K55305701 | SC-144 | -- | -- | -- | Details |
| C20009 | BRD-K55308802 | BRD-K55308802 | -- | -- | -- | Details |
| C20010 | BRD-K55311609 | BRD-K55311609 | -- | -- | -- | Details |
| C20011 | BRD-K55313038 | BRD-K55313038 | -- | -- | -- | Details |
| C20012 | BRD-K55316222 | BRD-K55316222 | -- | -- | -- | Details |
| C20013 | BRD-K55322029 | BRD-K55322029 | -- | -- | -- | Details |
| C20014 | BRD-K55330917 | BRD-K55330917 | -- | -- | -- | Details |
| C20015 | BRD-K55331619 | BRD-K55331619 | -- | -- | -- | Details |
| C20016 | BRD-K55332332 | BRD-K55332332 | -- | -- | -- | Details |
| C20017 | BRD-K55340188 | BRD-K55340188 | -- | -- | -- | Details |
| C20018 | BRD-K55341184 | BRD-K55341184 | -- | -- | -- | Details |
| C20019 | BRD-K55341496 | BRD-K55341496 | -- | -- | -- | Details |
| C20020 | BRD-K55341911 | BRD-K55341911 | -- | -- | -- | Details |
| C20021 | BRD-K55343182 | BRD-K55343182 | -- | -- | -- | Details |
| C20022 | BRD-K55343670 | BRD-K55343670 | -- | -- | -- | Details |
| C20023 | BRD-K55344148 | BU-224 | -- | -- | -- | Details |
| C20024 | BRD-K55345749 | BRD-K55345749 | -- | -- | -- | Details |
| C20025 | BRD-K55345900 | BRD-K55345900 | -- | -- | -- | Details |
| C20026 | BRD-K55362990 | BRD-K55362990 | -- | -- | -- | Details |
| C20027 | BRD-K55375480 | monensin | -- | -- | -- | Details |
| C20028 | BRD-K55380358 | BRD-K55380358 | -- | -- | -- | Details |
| C20029 | BRD-K55381473 | BRD-K55381473 | -- | -- | -- | Details |
| C20030 | BRD-K55385841 | BRD-K55385841 | -- | -- | -- | Details |
| C20031 | BRD-K55392659 | BRD-K55392659 | -- | -- | -- | Details |
| C20032 | BRD-K55393423 | BRD-K55393423 | -- | -- | -- | Details |
| C20033 | BRD-K55395145 | pemetrexed | DHFR; GART; TYMS | Thymidylate synthase inhibitor; Dihydrofolate reductase inhibitor | -- | Details |
| C20034 | BRD-K55399138 | BRD-K55399138 | -- | -- | -- | Details |
| C20035 | BRD-K55402144 | BRD-K55402144 | -- | -- | -- | Details |
| C20036 | BRD-K55414200 | BRD-K55414200 | -- | -- | -- | Details |
| C20037 | BRD-K55415928 | BRD-K55415928 | -- | -- | -- | Details |
| C20038 | BRD-K55420858 | mirin | MRE11 | MRE11A exonuclease inhibitor | -- | Details |
| C20039 | BRD-K55424922 | anpirtoline | HTR1B | Serotonin receptor agonist | -- | Details |
| C20040 | BRD-K55426263 | BRD-K55426263 | -- | -- | -- | Details |
| C20041 | BRD-K55430733 | WAY-629 | HTR2C | Serotonin receptor agonist | -- | Details |
| C20042 | BRD-K55432508 | BRD-K55432508 | -- | -- | -- | Details |
| C20043 | BRD-K55434198 | BRD-K55434198 | -- | -- | -- | Details |
| C20044 | BRD-K55437057 | BRD-K55437057 | -- | -- | -- | Details |
| C20045 | BRD-K55442031 | BRD-K55442031 | -- | -- | -- | Details |
| C20046 | BRD-K55442907 | BRD-K55442907 | -- | -- | -- | Details |
| C20047 | BRD-K55446881 | BRD-K55446881 | -- | -- | -- | Details |
| C20048 | BRD-K55452151 | BRD-K55452151 | -- | -- | -- | Details |
| C20049 | BRD-K55453160 | BRD-K55453160 | -- | -- | -- | Details |
| C20050 | BRD-K55454768 | TAS-301 | CAMK2A | Calcium/calmodulin dependent protein kinase inhibitor | -- | Details |
| C20051 | BRD-K55459289 | BRD-K55459289 | -- | -- | -- | Details |
| C20052 | BRD-K55460824 | BRD-K55460824 | -- | -- | -- | Details |
| C20053 | BRD-K55461955 | BRD-K55461955 | -- | -- | -- | Details |
| C20054 | BRD-K55462201 | AM-404 | TRPV1 | FAAH inhibitor; TRPV antagonist; Cyclooxygenase inhibitor | -- | Details |
| C20055 | BRD-K55465787 | BRD-K55465787 | -- | -- | -- | Details |
| C20056 | BRD-K55467482 | BRD-K55467482 | -- | -- | -- | Details |
| C20057 | BRD-K55468218 | spiperone | ADRA1A; DRD2; DRD3; DRD4; HTR1A; HTR2A; HTR7 | Dopamine receptor antagonist | -- | Details |
| C20058 | BRD-K55473186 | YL-61 | -- | -- | -- | Details |
| C20059 | BRD-K55478147 | isonicotinohydroxamic-acid | -- | -- | -- | Details |
| C20060 | BRD-K55478267 | BRD-K55478267 | -- | -- | -- | Details |
| C20061 | BRD-K55479099 | BRD-K55479099 | -- | -- | -- | Details |
| C20062 | BRD-K55482336 | BRD-K55482336 | -- | -- | -- | Details |
| C20063 | BRD-K55487965 | BRD-K55487965 | -- | -- | -- | Details |
| C20064 | BRD-K55489373 | BRD-K55489373 | -- | -- | -- | Details |
| C20065 | BRD-K55498981 | ST-022313 | -- | -- | -- | Details |
| C20066 | BRD-K55502647 | BRD-K55502647 | -- | -- | -- | Details |
| C20067 | BRD-K55504273 | BRD-K55504273 | -- | -- | -- | Details |
| C20068 | BRD-K55505527 | BRD-K55505527 | -- | -- | -- | Details |
| C20069 | BRD-K55507662 | BRD-K55507662 | -- | -- | -- | Details |
| C20070 | BRD-K55508908 | BRD-K55508908 | -- | -- | -- | Details |
| C20071 | BRD-K55510118 | BRD-K55510118 | -- | -- | -- | Details |
| C20072 | BRD-K55512740 | MK-8033 | MET | C-Met inhibitor | -- | Details |
| C20073 | BRD-K55518911 | BRD-K55518911 | -- | -- | -- | Details |
| C20074 | BRD-K55522699 | BRD-K55522699 | -- | -- | -- | Details |
| C20075 | BRD-K55522920 | BRD-K55522920 | -- | -- | -- | Details |
| C20076 | BRD-K55529781 | furegrelate | -- | -- | -- | Details |
| C20077 | BRD-K55533488 | BRD-K55533488 | -- | -- | -- | Details |
| C20078 | BRD-K55536701 | BRD-K55536701 | -- | -- | -- | Details |
| C20079 | BRD-K55538850 | BRD-K55538850 | -- | -- | -- | Details |
| C20080 | BRD-K55543534 | BRD-K55543534 | -- | -- | -- | Details |
| C20081 | BRD-K55557659 | BRD-K55557659 | -- | -- | -- | Details |
| C20082 | BRD-K55561254 | BRD-K55561254 | -- | -- | -- | Details |
| C20083 | BRD-K55562948 | BRD-K55562948 | -- | -- | -- | Details |
| C20084 | BRD-K55567017 | formononetin | ADH1C | Alcohol dehydrogenase inhibitor | -- | Details |
| C20085 | BRD-K55569103 | BRD-K55569103 | -- | -- | -- | Details |
| C20086 | BRD-K55569739 | BRD-K55569739 | -- | -- | -- | Details |
| C20087 | BRD-K55575531 | BRD-K55575531 | -- | -- | -- | Details |
| C20088 | BRD-K55578148 | BRD-K55578148 | -- | -- | -- | Details |
| C20089 | BRD-K55581069 | BRD-K55581069 | -- | -- | -- | Details |
| C20090 | BRD-K55584718 | BRD-K55584718 | -- | -- | -- | Details |
| C20091 | BRD-K55588166 | BRD-K55588166 | -- | -- | -- | Details |
| C20092 | BRD-K55591206 | BRD-K55591206 | -- | -- | epigallocatechin-gallate-(-) | Details |
| C20093 | BRD-K55596430 | BRD-K55596430 | -- | -- | -- | Details |
| C20094 | BRD-K55597137 | BRD-K55597137 | -- | -- | -- | Details |
| C20095 | BRD-K55598155 | BRD-K55598155 | -- | -- | -- | Details |
| C20096 | BRD-K55606442 | BRD-K55606442 | -- | -- | -- | Details |
| C20097 | BRD-K55612106 | BRD-K55612106 | -- | -- | -- | Details |
| C20098 | BRD-K55612480 | BRD-K55612480 | -- | -- | -- | Details |
| C20099 | BRD-K55623459 | BRD-K55623459 | -- | -- | -- | Details |
| C20100 | BRD-K55624132 | BRD-K55624132 | -- | -- | -- | Details |
| C20101 | BRD-K55630727 | BRD-K55630727 | -- | -- | -- | Details |
| C20102 | BRD-K55630925 | BRD-K55630925 | -- | -- | -- | Details |
| C20103 | BRD-K55630970 | BRD-K55630970 | -- | -- | -- | Details |